tissues WAT 8 . It is, therefore, speculated that the fiber component of PJT is largely responsible for the anti-obesity activity of PJT. In previous studies, the increased dietary fiber intake derived from PJT was compensated by decreasing the cellulose content of the diet 7, 8 . However, a compensatory decrease in dietary cellulose does not decisively address the question whether fi ber or other phytochemical components are responsible for the anti-obesity activity of PJT. In this context, PJT leaves have been reported to contain various phenolic compounds, including rutin and chlorogenic acid analogs 4 . Supplementation of the diet with rutin decreased fat accumulation and serum lipid levels in Wistar rats that were fed a high-fat diet 9 .
Shimoda et al. 10 demonstrated that chlorogenic acid in green coffee beans suppresses fat accumulation and liver TG elevation in ddY mice. It is possible that these phytochemicals are responsible for the anti-obesity activity of PJT. Therefore, this study examined the anti-obesity activities of PJT extracts to partially identify the component of PJT conferring the anti-obesity activity. Furthermore, the effect of PJT on lipid metabolism-related gene expression was studied to gain insight into the anti-obesity mechanism of PJT.
MATERIALS AND METHODS

Materials
PJT used in this study was cultivated and harvested in Yonaguni Island of Okinawa, Japan. PJT leaves and stems were freeze-dried and ground at Yonagunijima Yakusoen Co. Okinawa, Japan . The dried powder of PJT was analyzed by Japan Food Research Laboratories Tokyo, Japan , and its nutrient composition was found to be as follows: carbohydrate, 46.7 ; fi ber, 31.6 ; mineral, 9.8 ; protein, 7.6 ; and fat, 4.4 w/w . Casein, β-corn starch, cellulose, mineral mix, and vitamin mixes for AIN-76 rodent diets were purchased from Oriental Yeast Co., Ltd. Tokyo, Japan . DL-Methionine and choline bitartrate were purchased from Wako Pure Chemical Industries, Ltd. Osaka, Japan .
Preparation of extracts
Dried powder 200 g of PJT was extracted with 1 L of water, 50 ethanol or ethanol for 6 h at ambient temperature. These extracts were centrifuged at 3000 g for 10 min to remove insoluble matter. The supernatants were further fi ltered with fi lter paper no. 2 Toyo Roshi Kaisha, Tokyo, Japan , evaporated under vacuum, freeze-dried, and stored at 80 .
Animals and diets
Three-week-old male C57BL/6 mice were purchased from Japan SLC, Inc. Shizuoka, Japan . The animals were housed in a temperature-, humidity-, and light-controlled room 12-h light/dark cycle and were allowed free access to water. The mice were maintained on commercial chow for 7 days to allow acclimatization, and were, then, fed a semi-synthetic diet containing PJT powder or PJT extract for 4 weeks.
The authors fi rst examined the effect of the PJT extracts by using levels equivalent a diet supplemented with 20 powder, because the most clear-cut anti-obesity activity was noted with a diet supplemented with 20 PJT diet in a previous study 7 . Thus, PJT was extracted with water, 50 ethanol, or ethanol, and the extracts were added to the semi-synthetic diet to constitute 1.5 , 2.4 , and 0.8 , respectively, in Experiment Exp. 1 . This yielded levels of PJT extract equivalent to the levels contained in a 20 -PJT diet. In the second experiment Exp. 2 , the extract content of the diet was adjusted to 0.8 , i.e., the level of ethanol extract in Exp. 1. The compositions of the experimental diets for Exp.1 and 2 are shown in Tables 1 and 2 , respectively. In the dietary group with PJT powder, the additional protein, carbohydrate, fi ber, and fat derived from PJT were compensated by decreasing the corresponding nutrients: casein, sucrose, β-corn starch, cellulose, and corn oil.
All animals were pair fed on the diets and allowed free access to water. Mice were sacrifi ced after 6 h of fasting. Samples of serum, liver tissue, WAT, and soleus muscle tissue were collected and stored at 80 . The weights of the liver tissue and WAT were measured immediately after collection.
Lipid concentrations in the serum and liver
Serum levels of total cholesterol TC and triglyceride TG were determined using a commercial enzymatic kit Wako Pure Chemical Industries, Ltd., Osaka, Japan . Total lipids were extracted from the liver tissue by a previously described method 11 . Liver levels of TC and TG were determined by the Shoenheimer-Sperry method 12 and Fletcher s method 13 , respectively.
Lipid concentration in feces
Feces were collected during the last 3 days of the feeding period and dried. The TC and TG contents in the fecal samples were extracted by a previously described method 11 , and their levels were determined using commercial enzymatic assay kits Wako Pure Chemical, Osaka, Japan , as described previously 14 . Total bile acids were extracted from the feces with ethanol, and measured using the Total Bile Acid Test Wako kit Wako Pure Chemical, Osaka, Japan .
Adipocyte size
Epididymal adipose tissue was fixed in 10 buffered formalin, embedded in paraffi n, and stained with hematox-ylin and eosin for microscopic measurement of cell size, as described elsewhere 15 . The stained sections were viewed at 20 magnification, and photographed with a digital camera Olympus BX41, NY, USA . The images were converted into a binary format using Adobe Photoshop 5.0.1 software Adobe Systems, CA, USA and incorporated into Scion Image for measurement of cross-sectional areas. The total cross-sectional areas of at least 200 adipocytes were manually measured in 4 microscopic fi elds and were used to calculate the average cell surface area μm 2 .
Lipase inhibition assay
The lipase inhibition activities of PJT extracts were measured using Lipase Kit S DS Pharma Biomedical, Tokyo, Japan with minor modification of the manufacturer s instructions. Lipase solution contained 0.25 mg of porcine pancreatic lipase type Sigma, St. Louis, MO, U.S.A. in 1 mL of 0.1 M citrate buffer pH 6.0 . Reaction mixtures consisted of 217 μL of color solution, 9 μL of lipase, 4 μL of esterase inhibitor, and 30 μL of PJT extract 0.25, 0.5, and 1.0 mg/30 μL or distilled water as a control. After preincuba- 
Isolation of total RNA
Total RNA was extracted from 30 mg of liver, epididymal adipose and soleus muscle tissues by using the RNeasy Lipid Tissue Mini kit Qiagen, CA, USA . RNA purity was checked using agarose gel electrophoresis and quantified with a UV spectrophotometer. Total RNA 5 μg was reverse transcribed to produce cDNA by using PrimeScript TM 1st
Strand cDNA Synthesis kit Takara BIO Inc., Shiga, Japan . cDNA samples were stored at 80 as 50-μL aliquots.
Quantitative real-time RT-PCR
Quantitative real-time RT-PCR was performed on an iCycler Bio-Rad Laboratory, Tokyo, Japan using SYBR Green I Takara Bio Inc., Shiga, Japan and TaKaRa Ex Taq TM Hot Start Version Takara Bio Inc., Shiga, Japan , according to the manufacturer s instructions. The primer sequences are listed in Table 3 . Amplification of the target cDNA was checked by agarose gel electrophoresis and by identifi cation of its DNA sequence as described previously 16 . A standard curve for each gene was constructed by performing PCR with serially diluted, known concentrations of template, and used for the estimation of target mRNA, as described elsewhere 17 . All analyses were performed in duplicate and normalized to the expression of GAPDH in the hepatic tissue, β-actin in the adipose tissues, and Cypa in the soleus muscle tissue.
Total phenolic compound content
The total amount of phenolic compounds in the PJT extracts was determined according to the Folin-Denis assay as described previously 7 . Total phenolic content was expressed in mg/g of the extract, in epigallocatechin gallate equivalents.
HPLC analysis
Phenolic compounds in PJT extracts were analyzed using the Shimadzu HPLC 10A system Shimadzu, Kyoto, Japan . Samples were dissolved in 50 methanol and applied to ODS columns 150 4.6 mm I.D.; Nomura Chemical, Seto, Japan . The mobile phases were 0.2 trifl uoroacetic acid TFA in 10 methanol as the starting eluent and 0.2 TFA in 70 methanol as the limiting eluent. Samples were analyzed by the gradient program of the limiting eluent: 0-5 min, 50 100 and 5 40 min, 100 with a fl ow rate of 0.5 mL/min.
Statistical analysis
Statistical analysis was performed using one-way ANOVA, followed by inspection of the differences from the mean value of the control diet group by Dunnett s test. All statistical analyses were performed using the SAS statistical software program SAS Institute, Tokyo, Japan .
RESULTS
3.1 Growth parameters and weights of the liver and adipose tissues Of the diets containing PJT extract in Exp.1, reductions in WAT and body weight were observed for the experimental groups fed diets supplemented with 50 ethanol extract, ethanol extract, and 20 PJT powder Table 4 . The most pronounced anti-obesity activity was noted with the ethanol extract, despite the fact that it had the lowest PJT extract content in the diet. Table 5 summarizes the growth parameters and adipose tissue weights of mice fed a semi-synthetic diet containing 10 PJT powder or 0.8 PJT extract water, 50 ethanol, or ethanol extract in Exp. 2. There was no difference in food intake, and hence, in energy intake, between the dietary groups. The fi nal body weight of the ethanol extract group was significantly lower than that of the control group. Dietary groups fed PJT powder or extract showed a signifi cant increase in the relative liver weights compared with the control group.
Like in case of body weight, the ethanol extract, but not the water or 50 ethanol fractions, signifi cantly decreased the weight of WAT. Consistent with our previous results, PJT powder inhibited body weight gain and the deposition of fat in the adipose tissue 7 .
Lipid metabolism-related parameters
Of the PJT extracts, only ethanol extract significantly decreased the serum and liver levels of TG, although it did not decrease the levels of TC Table 6 . Increased fecal TG and decreased bile acid excretion was also observed only in ethanol extract group. The fecal TC tended to increase by diet supplementation with ethanol extract Table 6 .
Adipocyte size
The ethanol extract and PJT powder decreased the adipocyte size, as seen in Fig. 1 . The adipocyte size of mice fed water or 50 ethanol extract was largely similar to that of the control group. Figure 2 shows the in vitro lipase inhibition activity of the PJT extracts. The highest lipase inhibition activity was Table 3 Primer sequences used for quantitative real-time PCR. present in the ethanol extract, and to a lesser extent, in the 50 ethanol extract. No lipase inhibition activity was detected with the water extract.
Lipase inhibition activity
3.5 Analysis of gene expression in the liver, adipose tissues, and soleus muscle by real-time RT-PCR In order to gain insight into the anti-obesity mechanism of PJT extracts, their effects on lipid metabolism-related gene expression was studied with RT-PCR using the primers listed in Table 3 . Genes were chosen on the basis of the microarray gene expression analysis performed in our previous study, and by reviewing of the available literature. Figure 3 shows the effects of the PJT extracts on gene expression in the liver. CYP7A1 expression was signifi cantly decreased by PJT powder and ethanol extract. A tendency toward increased expression of PBEF1 and RORC genes was noted for PJT powder and ethanol extract, but without any statistical signifi cance. In contrast, the expression of FXRα and PPARα was significantly increased by supplementing the diet with ethanol extract. The expression of INSIG2 and DUSP1 tended to decrease when the diet was supplemented with PJT powder and ethanol extract.
Diet supplementation with PJT powder or ethanol extract signifi cantly increased the expression of RORC and PPARγ in the adipose tissue Fig. 4 . FXRα expression tended to increase in animals fed diets containing PJT powder or ethanol extract. The expression of the adipocyte size marker PEG1/MEST was signifi cantly lowered by both a: C57BL/6 mice were a fed high-fat diet supplemented with 0 % PJT, PJT powder (10 %), water extract (0.8 %), 50 % ethanol extract (0.8 %) or ethanol extract (0.8 %) for 4 weeks. Values are the mean SE of the data from 6 mice. Asterisk denotes a signifi cant difference when compared to the control (0 % PJT) group by Dunnett s test (*: p < 0.05; **: p < 0.01).
PJT powder and ethanol extract, consistent with the observation that the size of the adipocyte decreased in both diet groups, as exemplifi ed in Fig. 1 . Figure 5 shows the effects of the extracts on gene expression in the soleus muscle, one of the major tissues involved in the control of whole body energy metabolism. The ethanol extract signifi cantly elevated the expression of CPT1α in the soleus muscle. A similar trend was observed for CPT1β expression, but without any statistical signifi- cance. PJT powder and ethanol extract significantly increased the expression of UCP3. No signifi cant difference was seen for the other genes studied. Figure 6 shows the total phenolic compound content in the PJT extract. The concentrations of phenolic compounds in the water extract and 50 ethanol extract were largely comparable, and higher than that in the ethanol extract. Figure 7 depicts the HPLC chromatogram of the ethanol extract obtained using an ODS column. Eighteen peaks were noted in this chromatogram. Of the 18 components detected in this fraction, 3 were tentatively identified by their LC-MS-determined molecular masses and by comparing their retention time with authentic samples. Thus, neochlorogenic acid, chlorogenic acid, and rutin were identifi ed in this fraction. For descriptions of genes, see Table 3 . Mice were fed a control diet or an experimental diet supplemented with 10 % PJT powder, 0.8 % water extract, 0.8 % of 50 % PJT ethanol extract, or 0.8 % ethanol extract. Values have arbitrary units, and are shown as the mean ± SE of the data from 6 mice. Asterisk denotes a statistically signifi cant difference when compared to the 0 % diet group by Dunnett's test (*: p < 0.05).
Total phenolic compound contents of PJT extracts
Phenolic compounds in the ethanol extract
Fig. 4
Gene expression in the adipose tissue of the mice fed PJT or PJT extract (Exp. 2). For descriptions of genes, see Table 3 . Mice were fed a control diet or an experimental diet supplemented with 10 % PJT powder, 0.8 % water extract, 0.8 % of 50 % PJT ethanol extract, or 0.8 % ethanol extract. Values have arbitrary units, and are shown as the mean ± SE of the data from 6 mice. Asterisk denotes a statistically signifi cant difference when compared to the 0 % diet group by Dunnett's test (*: p < 0.05). For descriptions of genes, see Table 3 . Mice were fed a control diet or an experimental diet supplemented with 10 % PJT powder, 0.8 % water extract, 0.8 % of 50 % PJT ethanol extract or 0.8 % ethanol extract. Values have arbitrary units, and are shown as the mean ± SE of the data from 6 mice. Asterisk denotes a statistically signifi cant difference when compared to the 0% diet group by Dunnett's test (*: p < 0.05).
Fig. 6
Total phenolic compound concentration in the PJT extracts. The total amount of phenolic compounds in the PJT extracts was determined according to the Folin-Denis assay. The total phenolic content was expressed as mg/g extract in epigallocatechin gallate equivalents. Table 7 lists the relative peak intensities of the phenolic compounds in the 3 PJT extracts. Because of the hydrophobic nature of the ODS column, the peaks that elute earlier in the chromatogram represent compounds of higher polarity. Polarity, then, decreases with the increasing elution time. Thus, compounds that eluted later were more hydrophobic than those that eluted earlier. The ethanol extract was richer in hydrophobic components than the water or 50 ethanol extracts. Inspecting the relationship between the relative dietary level and the antiobesity activity across the dietary groups, we found higher correlation coeffi cients for peaks 10-15, with statistical signifi cance for peak 10.
DISCUSSION
Our previous study showed the anti-obesity activity of PJT in mice 7 . However, it remained obscure which component, fi ber or other ingredients in PJT, is associated with the anti-obesity activity. The present study aimed to address this question. The authors examined the effect of the PJT extracts in Exp. 1, by using levels equivalent to the levels observed in case of diet supplemented with 20 powder. Of the diets containing PJT extract, reductions in the weight of WAT and the body weight were observed for the experimental groups fed on 50 ethanol extract, ethanol extract, and 20 PJT powder Table 4 . This data a: Component number denotes the peak number as shown in Fig. 6 . b: Correlation between the relative dietary level and the decrease in the weight of the white adipose tissue (* p < 0.05 (n=6)).
suggests that the anti-obesity activity of PJT was extracted into the ethanol and 50 ethanol fractions. Thus, the most pronounced anti-obesity activity was noted with the ethanol extract, based on its supplementation level in the diet. The second experiment, using the same dietary levels of these extracts, confirmed the above-noted conclusions: a signifi cant reduction in the adipose tissue weight Table 5 and the lipid levels in the serum and liver were observed only with the ethanol extract Table 6 . This observation, therefore, unequivocally shows that anti-obesity phytochemicals occur in PJT. The active component appeared to be comparatively hydrophobic, i.e., more soluble in ethanol than in 50 ethanol. Thus, the active component was also, to a lesser extent, soluble in 50 ethanol, which may explain, why the anti-obesity activity of the 50 ethanol extract at higher levels of dietary supplementation was comparable to the anti-obesity activity of the ethanol extract Table 4 .
In this study, an increase in the relative liver weight was noted for the PJT powder and extract groups Tables 4 and 5 . However, the absolute liver weight of these groups was roughly comparable to that of the control group data not shown . Thus, the increase in the relative liver weight reflects a decrease in the body weight in the experimental groups, and does not indicate that the toxicity of PJT or its extracts induced enlargement of the liver. This view is supported by the data on the activities of ALT and AST, the liver injury markers, in our previous study 7 .
Several studies have demonstrated the anti-obesity activity of phenolic compounds in the plant extracts 5, 6, 18, 19 .
The present study analyzed the composition of phenolic compounds in PJT extracts. HPLC analyses identified 18 major phenolic compounds including neochlorogenic acid, chlorogenic acid, and rutin, in the extracts as illustrated in Fig. 7 . Inspection of the relationship between the relative dietary levels of these components and anti-obesity activity measured as a decrease in WAT compared to the control group across the dietary groups in Exp. 1 and Exp. 2 found higher correlation coeffi cients for peaks 10-15, with statistical significance for peak 10 Table 7 . Several studies have reported anti-obesity activity of neochlorogenic acid, chlorogenic acid, and rutin 5, 6, 9, 10 . The lower correlation coeffi cients for these components may negate the possibility that they were responsible for the inhibition of obesity in this study. Given that phenolic compounds are responsible for the anti-obesity activity, components of peaks 10-15 may be associated with the anti-obesity activity. However, the chromatogram at OD 280 nm only represents the separation of phenolic compounds, and not necessarily all the components of the extract. Therefore, it is possible that other constituents that lack an aromatic ring possess anti-obesity activity. Forthcoming studies will aim to purify and elucidate the anti-obesity activity of these components in the PJT ethanol extract. Increased fecal excretion of TG has been observed in the mice fed PJT 7 . The anti-obesity activities of several natural compounds have been ascribed to increased fecal fat excretion via the inhibition of lipase activity in previous studies 20, 21 . The present study, therefore, compared the lipase inhibition activities of the extracts, as shown in Fig.  2 . Of the 3 extracts, the ethanol extract showed the highest lipase inhibition activity. Thus, lipase inhibition activity may explain, in part, the increased fecal excretion in the PJT-fed mice Table 6 . The chief function of the adipose tissue is to store the excess energy consumed through diet, and to liberate this stored energy as free fatty acids when the energy spent exceeds the energy supplied from the diet. This buffering of energy accumulation is simply a reflection of the energy balance maintained between the intake and output of food. The decreased adipose tissue weight in the PJT-fed mice, therefore, may be a consequence of the inhibition of lipid absorption, leading to reduced lipid levels available for fat deposition in the adipose tissue. To what extent does lipase inhibition by the active component contribute to the entire lipid-lowering activity of PJT needs to be studied further in order to establish its relevance to the modulation of lipid metabolism in the PJT-fed mice. The active component in the ethanol extract increased the fecal excretion of TG and TC and decreased the fecal output of bile acid Table 6 . In general, increased fecal TG and TC excretion caused by impaired lipid absorption are accompanied by increased bile acid output 22, 23 . This is reasonably explained by decreased micelle formation due to the inhibition of lipid hydrolysis in the digestive tract 24 .
The active components of PJT probably inhibit lipase activity in the small intestine in vivo, as they did in vitro in this study Fig. 2 , and decrease lipid absorption, but not bile acid re-absorption. PJT ethanol extract and PJT powder decreased bile acid excretion, which suggests that the enterohepatic circulation of bile acid from the small bowel to the liver increased in the mice fed ethanol extract. This interpretation may be supported by the decreased expression of the CYP7A1 gene, which is under feedback regulation by the return fl ux of bile acid Fig. 3 . Thus, the active components in the ethanol extract may inhibit lipid absorption and on the other hand, accelerate the enterohepatic circulation of bile acid. This feature of PJT ethanol extracts contrasts with other prevailing observations for functional foods that inhibit lipid absorption, and hence, suppress high-fat diet-induced obesity 25 27 . In this context, increased expression of the FXRα gene was consistently observed in the previous and present studies. FXR, which encodes a bile acid sensor, is a key gene involved in bile acid and cholesterol homeostasis, TG metabolism, and inflammation 28 . Bile acids are primarily the endogenous ligands of FXR, and activate the transcription of FXR target genes upon binding to the ligand-binding domain of FXR. It has been reported that FXR activation decreases the fatty acid and TG biosynthesis as well as the production of very low-density lipoprotein in the liver 29 , while it upregulates the expression of PPARγ in the adipose tissue to increase the differentiation and normalize the functionality of adipose tissue 30 . Furthermore, administration of bile acids to mice increased energy expenditure in the brown adipose tissue and skeletal muscle 31 . In another study, FXR activation protected Zucker fa/fa obese rats from body weight gain and fat deposition in the liver and muscle tissue and reversed insulin resistance 32 . The enterohepatic circulation of bile acid, therefore, exerts important physiological effects on whole body lipid homeostasis. PJT, in our study, decreased fecal bile acid excretion Table 6 . This observation implies that PJT enhances the reabsorption of bile acids by the lower ileum, which, in turn, may activate FXR. The increased expression of FXR and the activation of FXR by bile acid may, therefore, underlie the decreased fat deposition in PJT-fed mice.
Modulation of the gene expression by the ethanol extract in the liver and adipose tissue was largely similar to the profi le induced by PJT powder. Our previous study using microarray and RT-PCR analyses revealed modulation of obesity-related gene expression in PJT-fed mice: RORC and PBEF1 were upregulated and DUSP1, INSIG2 and SERPINA12 were downregulated in the liver; FXRα and PPARγ were upregulated and PEG1/MEST, the size-marker of adipocytes, was downregulated in the adipose tissue 8 .
The trends seen in the previous study were reproduced in the mice fed PJT ethanol extract in the present study, albeit with some inconsistency in the statistical significance. Of the genes modulated by PJT powder, the physiological significance of the increased expression of RORC and PBEF1 in relation to the anti-obesity activity was discussed in our previous study, because the expression of these genes was prominently stimulated. The ethanol extract of PJT increased the expression of PPARα in the liver and PPARγ in adipose tissue. PPARα upregulates the expression of a number of genes critical for fatty acid β-oxidation and increases lipid catabolism 33 .
It is, therefore, likely that the ethanol extract lowered the liver lipid concentration by increasing fatty acid oxidation in the liver Table 6 . The PPARγ gene is a master regulator of adipogenesis in the adipose tissue. The physiological signifi cance of the increased expression of this gene induced by the ethanol extract is ambiguous, and somewhat, controversial. PPARγ belongs to the nuclear receptor super-family of the ligandactivated transcription factors 34 . The earliest event in adipogenesis is a brief burst of mesenchymal precursor cells, which is followed by cell cycle arrest and terminal differentiation 35 . PPARγ is induced at the stage of terminal differentiation in adipogenesis, and functions to complete the process that produces mature adipocytes 35 . Thus, the lipid-lowering activity of several natural compounds has been explained, in part, by downregulation of the PPARγ gene 36 .
In contrast to these observations, in the current study, PJT increased the expression of the PPARγ gene without any detrimental effect on obesity. Obesity is essentially due to overnutrition or positive energy balance. Adipose tissue functions to buffer the accumulation of the excess energy consumed through the diet and to provide energy as free fatty acids when the energy expenditure exceeds energy intake. Therefore, the decreased adipose tissue weight in the mice fed a PJT diet could be due to the reduced lipid levels available for adipogenesis. In addition to the liver and adipose tissue, the present study investigated the effect of PJT on gene expression in the muscle, the central tissue in energy expenditure. PJT ethanol extract or PJT powder upregulated the expression of UCP3, which encodes the main homolog of the uncoupling protein in the muscle. UCP3 may uncouple the transport of protons across the inner mitochondrial membrane from electron transport, thereby generating heat rather than energy. It has been suggested that UCP3 and UCP1 mediate thermogenesis, and several studies have indicated a protective role of UCP3 against obesity 37 39 . However, it now appears that the primary function of UCP3 is not to promote gross thermogenesis or energetic inefficiency 40 .
UCP3 and/or UCP2 are not normally thermogenic, and are activated under specific conditions by physiological or pharmacological activators such as superoxide or alkenals 41 . Furthermore, protecting the mitochondrial membrane from reactive oxygen species ROS is a putative role for UCP3 42 . It is suggested that UCP3 can be activated by an endogenous superoxide or by the product of lipid peroxidation which lowers the proton-motive force across the mitochondrial membrane and decreases ROS production 42 .
In this context, the increased expression of CPT1α in muscle Fig. 5 may indicate enhanced fatty acid transport into the mitochondria and increased β-oxidation. Superoxide production from the electron chain is high during fatty acid oxidation. This may trigger the formation of lipid peroxide to activate UCP3. Therefore, the physiological significance of PJT-induced increase in UCP3 expression observed in the current study needs to be examined further, especially with regard to its contribution to whole body energy expenditure as well as to anti-obesity activity.
In conclusion, to the best of our knowledge, this was the first study to show the presence of anti-obesity phytochemicals in PJT. These components appeared to reduce the TG input into the body by inhibiting lipase activity in the digestive tract and to lower the lipid levels by modulating obesity-related gene expressions in the liver, adipose tissue, and muscle, thereby modulating lipid metabolism. The phenol compounds abundant in PJT may be responsible for the anti-obesity activity of PJT; their involvement in this activity needs to be studied further.
